Effects of ezetimibe/simvastatin compared to simvastatin monotherapy in reducing C-reactive protein and low density lipoprotein-cholesterol

被引：0
|
作者：
Ballantyne, C. M.
Ridker, P.
Pearson, T.
Veltri, E.
Mitchel, Y. B.
Sisk, C. M. Mc Crary
Shah, A.
Maccubbin, D. L.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA
[4] Schering Plough Res Inst, Kenilworth, NJ USA
[5] Merck & Co Inc, Rahway, NJ 07065 USA
来源：
EUROPEAN HEART JOURNAL | 2006年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：945 / 945
页数：1
相关论文
共 50 条
  • [21] Effects of Simvastatin and Ezetimibe in Lowering Low-Density Lipoprotein Cholesterol in Subjects with Type 1 and Type 2 Diabetes Mellitus
    Ciriacks, Kevin
    Coly, Gerard
    Krishnaswami, Shanthi
    Patel, Shailendra B.
    Kidambi, Srividya
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (02) : 84 - 90
  • [22] Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients
    Bays, HE
    Stein, EA
    Shah, AK
    Maccubbin, DL
    Mitchel, YB
    Mercuri, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (09): : 942 - 946
  • [23] Low-density lipoprotein cholesterol goal attainment among patients with diabetes mellitus treated with ezetimibe plus simvastatin coadministration versus simvastatin alone
    McKenney, J
    Instull, W
    Lewin, A
    Maccubbin, D
    Lee, M
    Kush, D
    Mitchel, Y
    DIABETOLOGIA, 2004, 47 : A409 - A409
  • [24] Disparate Effects of Atorvastatin Compared With Simvastatin on C-Reactive Protein Concentrations in Patients With Type 2 Diabetes
    Sathyapalan, Thozhukat
    Atkin, Stephen L.
    Kilpatrick, Eric S.
    DIABETES CARE, 2010, 33 (09) : 1948 - 1950
  • [25] Disparate Effects of Atorvastatin Compared to Simvastatin on C-Reactive Protein Concentrations in Patients with Type 2 Diabetes
    Sathyapalan, Thozhukat
    Atkin, Stephen L.
    Kilpatrick, Eric S.
    DIABETES, 2010, 59 : A288 - A289
  • [26] Simvastatin lowers C-Reactive Protein by 14 days: An effect independent of that on LDL cholesterol
    Plenge, JK
    Weil, KM
    Grunwald, G
    Forster, J
    Poirier, P
    Eckel, RH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 222A - 222A
  • [27] Ezetimibe co-administered with simvastatin reduces C-reactive protein in a large cohort of hypercholesterolemic patients
    Sager, P
    Capece, R
    Lipka, L
    Strony, J
    Yang, B
    Suresh, R
    Mitchel, Y
    Veltri, E
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 148 - 148
  • [28] Ezetimibe/Simvastatin versus atorvastatin for attainment of apolipoprotein B and C-reactive protein goals: A VYVA substudy
    Ballantyne, CM
    Abate, N
    King, TR
    Yuan, Z
    Palmisano, J
    Tershakovec, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 335A - 335A
  • [29] Rosuvastatin plus ezetimibe for achievement of low-density lipoprotein cholesterol and C-reactive protein goals: results from the EXPLORER study
    Ballantyne, C. M.
    Sosef, F.
    Duffield, E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 943 - 943
  • [30] Influence of apolipoprotein E phenotype on changes in plasma levels of low-density lipoprotein-cholesterol and apolipoprotein B due to the effects of simvastatin
    Kobayashi, T
    Homma, Y
    Handa, S
    Nakamura, H
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1998, 8 (06) : 358 - 364
12345